Literature DB >> 12044285

Penicillin-resistant pneumococci-implications for management of community-acquired pneumonia and meningitis.

Hisham M Ziglam1, Roger G Finch.   

Abstract

Penicillin-nonsusceptible Streptococcus pneumoniae isolates have become increasingly prevalent worldwide. They are well-known agents of community-acquired infections such as otitis media, pneumonia and bacterial meningitis. Therapy of pneumococcal infections is made difficult by the emergence and spread of bacterial resistance to penicillin and other beta-lactams, as well as other antimicrobials such as macrolides. This article reviews current concepts of epidemiology and the implications of penicillin-nonsusceptible pneumococci for management of community-acquired pneumonia and meningitis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12044285     DOI: 10.1016/s1201-9712(02)90150-5

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  3 in total

1.  Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains.

Authors:  Helio S Sader; Thomas R Fritsche; Koné Kaniga; Yigong Ge; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

2.  In vitro activities of the novel cephalosporin LB 11058 against multidrug-resistant Staphylococci and Streptococci.

Authors:  Helio S Sader; David M Johnson; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

3.  Nationwide survey of the development of drug-resistant pathogens in the pediatric field in 2007 and 2010: drug sensitivity of Streptococcus pneumoniae in Japan (second report).

Authors:  Takeshi Tajima; Yoshitake Sato; Yoshikiyo Toyonaga; Hideaki Hanaki; Keisuke Sunakawa
Journal:  J Infect Chemother       Date:  2013-04-07       Impact factor: 2.211

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.